Bienvenue dans notre banque interrogeable de ressources et de documentation sur l’approvisionnement plus sécuritaire et autres sujets connexes.



We examined drug use practices, connectedness to other people who inject drugs, peer-to-peer injecting, and access to care among men who inject drugs in Melbourne, Australia.

Original research | 2023
2SLGBTQI+, Sex/Gender , Injecting drugs, About PWUD

We explored public support for safer supply programs in Saskatchewan and Alberta and identified predictors of support for this policy option.

Original research | 2023
Safer supply, Evidence base, Policy/Regulatory, Advocacy
Commentary | 2023
Harm reduction, Stigma, About PWUD

We explore individual-level, network-level, and community-level characteristics associated with MOUD uptake in young people who inject drugs and their support network members.

Original research | 2023
Youth, Injecting drugs, Substitution/OAT, Stigma, About PWUD

The objective of our study was to explore mental health clinician attitudes towards substance use and associations with clinical experience and education level

Original research | 2023
About prescribers, Stigma

In examining past policies, practices, and discourse that support heroin regulation and drug prohibition, the drivers of the current illegal drug overdose death epidemic in Canada are brought more

Original research | 2021
Policy/Regulatory, Justice system/law enforcement, Equity

We explored the likelihood of securing a new primary care provider (PCP) among people with varying histories of opioid use who had recently lost access to their PCP.

Original research | 2021
About PWUD, Stigma, Equity

This article examines how clinics’ take-home dosing policies have affected patients’ experiences of treatment and lives in general.

Original research | 2021
Carries/take-home doses, Stigma, Substitution/OAT, About PWUD, Policy/Regulatory, Barriers and enablers

This study evaluated how telemedicine as a modality for opioid agonist treatment compares to in-person care

Original research | 2021
Digital health
Livre | 2022
les drogues hallucinogènes/psychédéliques, la réduction des méfaits

To investigate excess costs of buprenorphine-naloxone due to unmerited market exclusivity (no legal patent or data protection) in Canada.

Original research | 2023
Policy/Regulatory, Barriers and enablers, Substitution/OAT

We explored perspectives of people who use drugs (PWUD) on the changing drug supply in Oregon, experiences of and response to fentanyl-involved overdose, and recommendations from PWUD to reduce ove

Original research | 2022
About PWUD, Harm reduction, Decriminalization/legalization, Stigma, Illegal drugs
Letter | 2022
About PWUD, Policy/Regulatory, Equity, Advocacy

To assess for long-term positive effects of buprenorphine treatment (BT) on opioid use disorder (OUD) at a Nishnawbe Aski Nation high school clinic

Original research | 2020
Indigenous, Youth, Substitution/OAT, About PWUD

Collecting in-person UDS may not always be feasible, contributing to the need to understand factors that influence the validity of self-reported substance use.

Original research | 2023
About PWUD, Clinical guidance

Traditionally, “success” in MOUD treatment is measured in terms of program retention, adherence to MOUD, and abstinence from opioid and other drug use.

Original research | 2023
About PWUD, Substitution/OAT, Barriers and enablers

Drawing on data from U.S.

Original research | 2023
Mortality, Overdose, About PWUD, Policy/Regulatory

This study identified patient profiles in terms of their quality of outpatient care use, associated sociodemographic and clinical characteristics, and adverse outcomes based on frequent emergency d

Original research | 2023
Mortality, About PWUD

This study estimated cost savings from expanding access to substance use disorder (SUD) treatment for persons with opioid use disorders (OUD).

Original research | 2023

The aim of this study was to examine what drives increases in opioid overdose death among Black Americans based on the experience of key stakeholders.

Original research | 2023
Equity, Overdose, Mortality

Affiner votre recherche

Mots clés